HROW.NASDAQHarrow, INC

SCHEDULE: Opaleye Management Reports 6.44% Stake in Harrow, Inc.

Sentiment:

Beneficial Ownership Filing


Opaleye Management Inc., Opaleye L.P., and James Silverman have jointly filed a Schedule 13G, disclosing beneficial ownership of 2,400,000 shares of Harrow, Inc. common stock, representing 6.44% of the outstanding shares.

Summary

  • Opaleye Management Inc., Opaleye L.P., and James Silverman have collectively acquired a beneficial ownership stake of 2,400,000 shares in Harrow, Inc.
  • This holding represents 6.44% of the company's outstanding common stock.
  • The filing is an amendment (Amendment No. 9) to a Schedule 13G, indicating a change or update in their holdings.
  • The shares are held by Opaleye L.P., with Opaleye Management Inc. acting as the investment adviser and James Silverman as the controlling person of the adviser.
  • The filing clarifies that this is not an admission of beneficial ownership for all purposes under Section 13 of the Securities Exchange Act of 1934.
  • The total number of outstanding shares of Harrow, Inc. common stock is reported as 37,275,107 as of May 6, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It's a standard disclosure of ownership and does not inherently signal positive or negative performance for Harrow, Inc., but rather an investment position taken by Opaleye.

Positives

  • Significant ownership stake of 6.44% in Harrow, Inc. by Opaleye entities and James Silverman.
  • Clear disclosure of beneficial ownership, providing transparency to the market.
  • The filing indicates a structured approach to investment management through Opaleye L.P. and its adviser, Opaleye Management Inc.

Negatives

  • The filing does not provide specific details on the acquisition cost or the investment strategy behind acquiring this stake.
  • The nature of the 'shared power to vote or direct the vote' and 'shared power to dispose or direct the disposition' is not elaborated upon beyond the aggregate amount.

Risks

  • Potential for increased scrutiny from regulatory bodies due to the significant ownership stake.
  • The filing does not detail any specific risks associated with Harrow, Inc. itself, focusing solely on the ownership disclosure.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from Harrow, Inc. It pertains to the ownership disclosure by Opaleye Management Inc., Opaleye L.P., and James Silverman.

Management Comments

  • The filing of this statement shall not be construed as an admission that any Reporting Person is the beneficial owner of any securities covered by this statement for purposes of Section 13 of the Securities Exchange Act of 1934, as amended, or otherwise.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant stakeholders to disclose their ownership stakes. This filing indicates a substantial investment by Opaleye entities in Harrow, Inc., which could signal confidence or a strategic interest in the company's future performance within its industry.

Stakeholder Impact

  • Shareholders: Increased transparency regarding significant ownership, potentially influencing market perception and trading activity.
  • Management of Harrow, Inc.: Awareness of a substantial institutional investor's stake, which may lead to engagement on corporate strategy or governance.
  • Potential Investors: The filing provides information about a key stakeholder, which can be a factor in their investment decisions.

Next Steps

  • The Reporting Persons may continue to monitor their investment in Harrow, Inc.
  • Further amendments to the Schedule 13G may be filed if there are changes in beneficial ownership.

Key Dates

DateDescription
2026-05-06Date as of which Harrow, Inc. reported 37,275,107 shares of Common Stock outstanding.
2026-05-11Date Harrow, Inc. filed its Form 10-Q reporting outstanding shares.
2026-06-30Date of Event Which Requires Filing of this Statement (Schedule 13G Amendment No. 9).
2026-07-31Date of execution of the Joint Filing Agreement and signature date for the Schedule 13G.

Keywords

Harrow Inc., Opaleye Management, Opaleye L.P., James Silverman, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.